- Conditions: Barrett's Esophagus; Esophageal Neoplasms
Interventions: Device: Radiofrequency Ablation(RFA) by HALO device.; Device: Endoscopic mucosal resection(EMR) by mucosectomy kit.
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center; American Society for Gastrointestinal Endoscopy; Cook Incorporated; Washington University School of Medicine; Columbia University; University of Chicago
Recruiting - verified April 2012 - Conditions: Barrett's Esophagus; Gastroesophageal Reflux Disease
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center
Not yet recruiting - verified April 2012 - Conditions: Barrett's Esophagus; Gastroesophageal Reflux Disease
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center
Recruiting - verified April 2012 - Conditions: Gastroesophageal Reflux Disease; Gastritis
Intervention: Other: Histological analysis
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified April 2012 - Condition: Barrett's Esophagus
Intervention: Genetic: response to therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Barrett's Esophagus
Interventions: Drug: Omeprazole; Drug: Melatonin
Sponsors: Aragon Institute of Health Sciences; Aragon Institute of Health Sciences
Not yet recruiting - verified March 2012 - Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Device: 24 hour ambulatory pH study; Procedure: Upper endoscopy
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: Esophageal Cancer
Intervention: Device: wireless pulse oximeter (Wipox)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2012 - Conditions: Esophageal Deviation; Atrial Fibrillation; Ablation
Intervention: Procedure: esophageal deviation
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; Boston Scientific Corporation
Recruiting - verified March 2012 - Conditions: Esophageal Cancer; Gastric Cancer
Intervention: Drug: Afatinib (BIBW 2992)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified April 2012 - Condition: Esophageal Cancer
Interventions: Radiation: Proton Beam Therapy (PBT); Radiation: Intensity Modulated Radiation Therapy (IMRT); Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Barrett's Esophagus
Intervention:
Sponsors: NinePoint Medical; NinePoint Medical
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
Interventions: Drug: FOLFOX regimen; Drug: docetaxel; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Barrett's Esophagus
Intervention:
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified December 2011 - Condition: Advanced Esophageal Carcinoma
Intervention: Drug: mFOLFIRI+Nimotuzumab
Sponsors: Peking University; Peking University
Recruiting - verified November 2011 - Conditions: Short Segment Barrett's Esophagus; Long Segment Barrett's Esophagus
Interventions: Drug: Omeprazole; Drug: Vitamin D3; Drug: Vitamin D3; Procedure: upper endoscopy
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center
Recruiting - verified May 2012 - Condition: Carcinoma of the Oesophagus
Interventions: Drug: Olaparib; Radiation: Radical external beam radiotherapy, 50Gy in 25 fractions
Sponsors: Christie Hospital NHS Foundation Trust; Christie Hospital NHS Foundation Trust; Cancer Research UK (New Agents Committee); AstraZeneca
Not yet recruiting - verified December 2011 - Conditions: Esophageal Cancer; Precancerous Condition
Interventions: Drug: metformin hydrochloride; Other: placebo
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Barrett`s Esophagus
Interventions: Other: biopsies; Other: biopsy
Sponsors: Johannes Gutenberg University Mainz; Johannes Gutenberg University Mainz
Recruiting - verified September 2011 - Condition: Barrett's Esophagus
Intervention: Device: MGH Optical Frequency Domain Imaging (OFDI) system
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: Malignant Neoplasm of Esophagus; Malignant Neoplasm of Stomach
Interventions: Drug: Oxaliplatin; Drug: Folinic Acid; Drug: 5-fluoro-uracil; Drug: panitumumab; Drug: AMG102
Sponsors: UNICANCER; UNICANCER
Recruiting - verified September 2011 - Condition: Esophageal Cancer
Intervention: Other: fluid optimisation
Sponsors: University Hospital, Linkoeping; University Hospital, Linkoeping
Recruiting - verified October 2011 - Condition: Barrett's Esophagus
Intervention: Device: optical frequency domain imaging (OFDI) system
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction
Interventions: Drug: Carboplatin AUC; Drug: Paclitaxel; Drug: lapatinib
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center
Recruiting - verified March 2012 - Conditions: Barrett Esophagus; Esophageal Adenocarcinoma
Intervention: Drug: GI heptapeptide
Sponsors: University of Michigan; University of Michigan
Recruiting - verified January 2012 - Conditions: GERD; Barrett's Esophagus
Interventions: Drug: Fluorescein; Drug: Proflavine hemisulfate
Sponsors: Anandasabapathy, Sharmila, M.D.; Anandasabapathy, Sharmila, M.D.
Recruiting - verified June 2011 - Conditions: Barrett's Esophagus; Intraepithelial Neoplasia
Intervention: Drug: proflavine
Sponsors: Anandasabapathy, Sharmila, M.D.; Anandasabapathy, Sharmila, M.D.; William Marsh Rice University
Recruiting - verified September 2011 - Condition: Lung Cancer
Interventions: Procedure: Nitric oxide breath test; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Barrett's Esophagus; Gastroesophageal Reflux Disease (GERD); Intestinal Metaplasia
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Barrett's Esophagus; Intestinal Metaplasia; Gastroesophageal Reflux Disease (GERD)
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; American Society for Gastrointestinal Endoscopy
Recruiting - verified May 2012 - Conditions: Melena; Hematemesis; Peptic Ulcer Hemorrhage; Variceal Hemorrhage
Intervention: Device: Video capsule endoscopy (Pillcam Eso2)
Sponsors: George Washington University; George Washington University; Given Imaging Ltd.
Recruiting - verified June 2011 - Conditions: Carcinoma, Squamous Cell; Adenocarcinoma of the Esophagus and Gastric Cardia
Interventions: Drug: Chemotherapy; Radiation: Radiochemotherapy
Sponsors: Karolinska University Hospital; Karolinska University Hospital; Umea University Hospital; University Hospital Orebro; Sahlgrenska University Hospital, Sweden; Ullevaal University Hospital; Haukeland University Hospital, Bergen; Oslo University Hospital; St. Olavs Hospital; Malarhospital Eskilstuna
Recruiting - verified February 2012 - Conditions: Barrett Oesophagus; Low Grade Dysplasia
Interventions: Procedure: Endoscopic radiofrequency ablation; Other: Endoscopic surveillance
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2011 - Conditions: Malignant Dysphagia; Esophageal Cancer
Interventions: Radiation: Brachytherapy; Procedure: Stent insertion
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified June 2011 - Conditions: Esophageal Cancer; Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine; Drug: Azacitidine; Drug: Azacitidine; Drug: Oxaliplatin; Drug: Oxaliplatin; Drug: Epirubicin; Drug: Epirubicin; Drug: Capecitabine; Drug: Capecitabine
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: Esophageal Cancer
Interventions: Radiation: Conformal 3D Radiotherapy with " ENI "-type prophylactic irradiation of the lymph node; Radiation: Boost; Radiation: Boost; Drug: chemotherapy: FOLFOX 4
Sponsors: Centre Georges Francois Leclerc; Centre Georges Francois Leclerc; National Cancer Institute, France; UNICANCER-GI; SFRO:French Society of Radiation Oncology
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Drug: FOLFOX regimen; Drug: carboplatin; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Stage II Esophageal Cancer
Interventions: Biological: panitumumab; Drug: oxaliplatin; Drug: leucovorin calcium; Drug: fluorouracil; Radiation: radiation therapy; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: high performance liquid chromatography; Genetic: DNA analysis; Genetic: polymorphism analysis; Other: pharmacological study; Other: pharmacogenomic studies
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Barrett's Esophagus; Erosive Esophagitis; Gastroesophageal Reflux Disease(GERD)
Intervention:
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Esophageal Cancer
Intervention: Device: HANAROSTENT TM covered Esophageal Stent
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; M.I.Tech Co., Ltd.
Recruiting - verified January 2012 - Condition: Barrett's Esophagus
Interventions: Drug: YF476; Drug: Placebo
Sponsors: Columbia University; Columbia University; Trio Medicines Ltd.
Not yet recruiting - verified January 2012 - Conditions: High-grade Dysplasia in Barrett Esophagus; Non Small Cell Lung Cancer; Esophageal Cancer
Interventions: Drug: Solar Protection Formula SPF® 60; Procedure: Photobiological testing; Procedure: Blood collection
Sponsors: Pinnacle Biologics Inc.; Pinnacle Biologics Inc.
Not yet recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Drug: gefitinib; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Oncology Clinical Trials Office at University of Oxford
Recruiting - verified August 2011 - Conditions: Stomach Cancer; Esophageal Cancer
Interventions: Biological: Ramucirumab; Drug: Placebo; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-Fluorouracil
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Esophagus; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Stage IV Esophageal Cancer; Stage IV Gastric Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: everolimus; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: microarray analysis
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Esophageal Cancer
Interventions: Drug: Docetaxel; Drug: 5-FU; Radiation: Radiotherapy; Procedure: Esophagectomy; Drug: Dexamethasone
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Solid Tumors
Intervention: Drug: IMAB362
Sponsors: Ganymed Pharmaceuticals AG; Ganymed Pharmaceuticals AG
Recruiting - verified February 2012 - Condition: Barrett's Esophagus
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Biological: trastuzumab; Drug: carboplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Squamous Cell Carcinoma of the Esophagus; Stage III Esophageal Cancer; Stage III Gastric Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer
Interventions: Drug: pralatrexate; Drug: oxaliplatin; Other: pharmacogenomic studies; Genetic: RNA analysis; Genetic: polymorphism analysis; Genetic: polymerase chain reaction; Genetic: microarray analysis; Procedure: esophagogastroduodenoscopy; Procedure: biopsy; Other: laboratory biomarker analysis
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Comprehensive Cancer Network
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Biological: cixutumumab; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified June 2011 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinomas of the Gastroesophageal Junction; Recurrent Esophageal Cancer; Squamous Cell Carcinoma of the Esophagus; Stage IV Esophageal Cancer
Interventions: Drug: pralatrexate; Drug: docetaxel; Radiation: fludeoxyglucose F 18; Procedure: positron emission tomography
Sponsors: Ohio State University Comprehensive Cancer Center; Jeffrey Rose; National Comprehensive Cancer Network
Recruiting - verified May 2012 - Condition: Barrett's Mucosa With High Grade Intraepithelial Neoplasia (HGIEN)
Intervention: Procedure: Endoscopic mucosal resection
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified January 2012 - Condition: Barrett's Esophagus, Esophageal Intraepithelial Neoplasia
Intervention: Procedure: endomicroscopy
Sponsors: Johns Hopkins University; Johns Hopkins University; American Society for Gastrointestinal Endoscopy; Pentax Medical Corporation
Recruiting - verified March 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Biological: cetuximab; Drug: cisplatin; Drug: docetaxel; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy
Sponsors: Swiss Group for Clinical Cancer Research; Swiss Group for Clinical Cancer Research
Recruiting - verified May 2012 - Conditions: Barrett Esophagus; Esophageal Cancer
Intervention: Drug: ursodiol
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Esophageal Cancer; Gastro-esophageal Junction Cancer
Interventions: Behavioral: Home visits; Behavioral: standard
Sponsors: Odense University Hospital; Michael Bau Mortensen; Odense University Hospital
Recruiting - verified November 2011 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
Interventions: Drug: capecitabine; Drug: docetaxel; Drug: fluorouracil; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Esophageal Cancer; Gastroesophageal Junction Cancer
Interventions: Drug: Sorafenib, administered orally; Procedure: CT/MRI
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Bayer
Recruiting - verified April 2012 - Conditions: Gastrointestinal Disease; Esophageal Cancer; Lung Cancer
Interventions: Procedure: Breathing Test; Behavioral: Respiratory Symptoms Questionnaire; Procedure: Pet Scan
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Gastroesophageal Reflux Disease
Intervention: Procedure: Esophageal biopsy
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Esophageal Cancer
Interventions: Drug: FOLFOX regimen; Drug: cisplatin; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); UNICANCER
Recruiting - verified August 2011 - Conditions: Gastrointestinal Disease; Esophageal Cancer
Interventions: Procedure: PET/CT (FDG PET/CT); Other: Biomarker Testings
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Biological: panitumumab; Drug: cisplatin; Drug: docetaxel; Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); American College of Surgeons; National Cancer Institute (NCI)
Recruiting - verified June 2011 - Conditions: Barrett's Esophagus; Esophageal Cancer
Intervention: Device: CryoSpray Ablation(TM)
Sponsors: CSA Medical, Inc.; CSA Medical, Inc.
Recruiting - verified January 2012 - Conditions: Barrett's Esophagus With or Without Dysplasia; Squamous Dysplasia of the Esophagus; Esophageal Cancer (Any Stage)
Intervention:
Sponsors: CSA Medical, Inc.; CSA Medical, Inc.
Recruiting - verified January 2012 - Condition: Esophagus Cancer
Intervention: Radiation: Tomotherapy
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified September 2011 - Conditions: Barrett's Esophagus; Neoplasms; Gastroesophageal Reflux
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center
Recruiting - verified April 2012 - Conditions: Barrett's Esophagus; High Grade Dysplasia
Interventions: Procedure: Photodynamic therapy; Procedure: radiofrequency ablation of barrett's esophagus
Sponsors: Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Conditions: Barrett's Esophagus; Early Esophageal Adenocarcinoma
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified March 2012 - Conditions: Barrett's Esophagus; Early Esophageal Adenocarcinoma
Intervention: Biological: Biopsy
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified March 2012 - Conditions: Barrett's Esophagus; Esophageal Neoplasms
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center; TAP Pharmaceutical Products Inc.
Recruiting - verified April 2012 - Conditions: Barrett Esophagus; Gastroesophageal Reflux
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center
Recruiting - verified April 2012 - Conditions: Barrett's Esophagus; Gastroesophageal Reflux Disease; Esophageal Adenocarcinoma
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; Kansas City Veteran Affairs Medical Center
Recruiting - verified April 2012 - Condition: Esophageal Cancer
Interventions: Biological: cetuximab; Drug: cisplatin; Drug: fluorouracil; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: National Cancer Institute (NCI); Federation Francophone de Cancerologie Digestive
Recruiting - verified October 2007 - Conditions: Barrett's Esophagus; GERD
Interventions: Procedure: Endoscopy; Procedure: Radiofrequency ablation protocol; Procedure: Endoscopic mucosal resection protocol
Sponsors: Valley Health System; Valley Health System
Recruiting - verified August 2011 - Condition: Oesophagogastric Cancer
Interventions: Biological: bevacizumab; Drug: capecitabine; Drug: cisplatin; Drug: epirubicin hydrochloride; Procedure: adjuvant therapy; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: Medical Research Council; Professor David Cunningham; Cancer Research UK
Recruiting - verified January 2012 - Conditions: Barrett Esophagus; Esophageal Neoplasm; Gastroesophageal Reflux
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Esophageal Cancer
Interventions: Biological: cetuximab; Drug: fluorouracil; Drug: oxaliplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Technische Universität München
Recruiting - verified May 2007 - Conditions: Thoracic Malignancy; Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: Carcinoma, Small Cell; Carcinoma, Non-small-cell Lung; Esophageal Neoplasms; Mesothelioma
Interventions: Drug: Depsipeptide; Drug: Flavopiridol (alvocidib)
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Barrett Esophagus; Esophageal Diseases
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011 - Condition: Esophageal Cancer
Interventions: Drug: cisplatin; Drug: epirubicin hydrochloride; Drug: fluorouracil; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified March 2007
 |
Join Clinical trials for Esophagus Disorders |
